Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma

V Máximo1, P Soares, R Seruca

  • 1Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Dr. Roberto Frias s/n, 4200 Porto, Portugal. vmaximo@ipatimup.pt

Genes, Chromosomes & Cancer
|September 11, 2001
PubMed

Insights

Mitochondrial DNA (mtDNA) mutations are common in gastric cancer but not linked to microsatellite instability (MSI). However, large mtDNA deletions are predominantly found in MSI-negative tumors, suggesting a potential link.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Mitochondrial DNA (mtDNA) alterations, including large deletions and mutations, are observed in various human cancers.
  • The association between these mtDNA changes and nuclear microsatellite instability (MSI) status in cancer cells is not well-established.

Purpose of the Study:

  • To investigate the relationship between mtDNA alterations (mutations and common deletions) and MSI status in gastric carcinoma.
  • To characterize the types and locations of mtDNA mutations in gastric cancer.

Main Methods:

  • Analysis of five mitochondrial genes and two D-loop regions using PCR/SSCP and sequencing in 32 gastric carcinoma samples.
  • Samples were pre-screened for MSI and mitochondrial common deletion.
  • Characterization of mtDNA mutations, including transitions, insertions, and deletions.

Main Results:

  • Mitochondrial DNA alterations were detected in 81% of gastric carcinomas.
  • Mutations primarily occurred in the D-loop, ND1, and ND5 genes, predominantly as transitions.
  • Mitochondrial common deletion showed a trend towards an inverse relationship with mtDNA mutations and was significantly associated with MSI-negative tumors.

Conclusions:

  • Mitochondrial DNA mutations in gastric cancer are not significantly related to MSI status.
  • Mitochondrial common deletions are largely restricted to MSI-negative gastric carcinomas, a finding that warrants further investigation in larger cohorts and other cancer types.